Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT01133223

Withdrawn

Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke

Stroke
NCT01635803

Unknown

Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO) (BRVO)

Retinal Vein Occlusion
NCT01854476

Unknown

Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze

Bleeding | Coagulopathy
NCT01473251

Completed

Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration

Diabetic Macular Edema | Exudative Macular Degeneration
NCT01512966

Completed

Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema) (VIVID-Japan)

Macular Edema
NCT01612286

Unknown

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
NCT00636298

Withdrawn

Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy

Esophageal Carcinoma
NCT01150266

Withdrawn

Study for the Use of Alteplase in Patients Who Awaken With Stroke (AWOKE)

Ischemic Stroke
NCT00109772

Terminated

Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1 (CRPS-002)

Complex Regional Pain Syndrome, Type I
NCT01062152

Completed

Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome
NCT01689558

Unknown

Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer

1、Enough Cases | 2、Elekta Precise 1343 Digital Control Electron Linear Accelerator | Can Undertake Nasopharyngeal Carcinoma Specimens in the Materia， | Image Department of Nose Pharynx Ministry MRI Dynamic Testing,
NCT00718471

Completed

STEMI Treated With Primary Angioplasty and Intravenous Lovenox or Unfractionated Heparin (UFH) (ATOLL)

Primary PCI - STEMI
NCT00243906

Completed

Interventional Management of Stroke (IMS) II Study

Stroke
NCT00445406

Completed

Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer
NCT00253851

Completed

Does Thinning the Blood During Surgery Prevent Blood Clots Following Total Knee Replacement Surgery

Osteoarthritis | DVT
NCT01487629

Unknown

Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema (IBERA-DME)

Diabetic Retinopathy | Macular Edema
NCT00454389

Unknown

A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration (CABERNET)

Macular Degeneration
NCT00740922

Completed

Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers

Neoplasms | Diabetic Foot | Platelet-Derived Growth Factor
NCT00480636

Completed

Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients

Acute Deep Vein Thrombosis
NCT00710229

Unknown

Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration (MANTA)

Age Related Macular Degeneration
NCT00381511

Completed

Deferment of Imaging for Pulmonary Embolism

Pulmonary Embolism
NCT03732105

Recruiting

Randomized Study of Adjuvant Radiotherapy After Curative Resection of HCC With Narrow Margin (RAISE) (RAISE)

Hepatocellular Carcinoma | Hepatectomy | Radiotherapy
NCT04091217

Completed

Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

Melanoma
NCT05510427

Withdrawn

Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification

Cholangiocarcinoma | Liver Cancer
NCT05874583

Completed

Prevention of Bleeding in Total Joint Replacement: Combined Route Administration of Tranexamic Acid

Arthroplasty, Replacement, Knee | Blood Transfusion | Arthroplasty, Replacement, Hip | Tranexamic Acid
NCT03641326

Terminated

Sunitinib in Sarcomas of the Central Nervous System

Gliosarcoma | Central Nervous System Sarcoma
NCT01024920

Completed

Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib.

Carcinoma, Renal Cell
NCT04137588

Unknown

Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

Advanced Non-squamous Non-small Cell Lung Cancer
NCT02976246

Completed

Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients (RenaKvit)

Cardiovascular Disease | Bone Disease | Endstage Renal Disease | Vitamin K Supplementation
NCT04425681

Unknown

Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer (OWBLM)

Non-small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal Metastasis
NCT00421538

Completed

Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT) (CACTUS-PTS)

Distal (Calf) Deep-vein Thrombosis
NCT02917525

Unknown

Bicuspid Aortic Valve Stenosis and the Effect of vItamin K2 on Calciummetabolism on 18F-NaF PET/MRI (BASIK2)

Aortic Valve Stenosis | Bicuspid Aortic Valve
NCT01402817

Terminated

Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas

Neurofibromatosis | Plexiform Neurofibromas | NF1
NCT01064310

Completed

Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer (PISCES)

Carcinoma, Renal Cell
NCT00398320

Completed

Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors

Neuroendocrine Tumors
NCT02708628

Completed

The Efficacy of Extract of Allium Cepae, Allantoin and Heparin in Patients With Proven Scar Development

Cicatrix
NCT01285661

Completed

Optimal Duration of Anticoagulation in Deep Venous Thrombosis (MORGAGNI)

Deep Vein Thrombosis of Lower Limb | Lower Extremity Deep Venous Thrombosis Recurrent
NCT00553696

Completed

Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer

Stomach Neoplasms
NCT00484939

Completed

A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer

Colorectal Cancer
NCT00514137

Completed

Sunitinib in Treating Patients With Relapsed Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma
NCT00009919

Terminated

SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment

Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer
NCT00642551

Completed

Beneficial Effects of Long Term Menaquinone-7

Arteriosclerosis | Bone Loss
NCT00121836

Completed

A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Breast Cancer
NCT00345761

Completed

Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer

Colorectal Cancer
NCT03097601

Completed

ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to Sunitinib (SUNITRES)

Metastatic Kidney Cancers
NCT01597336

Completed

Treatment of Abdominal Abscesses With or Without Fibrinolysis

Abdominal Abscess | Tissue Plasminogen Activator
NCT01920984

Completed

Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy (VL)

Proliferative Diabetic Retinopathy
NCT01866657

Terminated

Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery

Hypoxia
NCT02149173

Terminated

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Recurrent Breast Carcinoma | Estrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7
NCT04846478

Active, not recruiting

Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC

Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate Cancer

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations